We came across a bullish thesis on BioNTech SE on Memyselfandi007’s Substack. In this article, we will summarize the bulls’ thesis on BNTX. BioNTech SE's share was trading at $103.80 as of March 4th. BNTX’s trailing and forward P/E were 166.87 and 7.04 respectively according to Yahoo Finance.
[caption id="attachment_945280" align="aligncenter" width="750"]BioNTech SE (BNTX) has transitioned from a COVID-19 vaccine pioneer to a diversified biotech company with a growing focus on oncology, positioning itself for...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.